Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Mitral Valve Insufficiency

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Mitral Valve Insufficiency in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montastruc, F1
Montastruc, G1
Vigreux, P1
Bruneval, P1
Guilbeau-Frugier, C1
Cron, C1
Bagheri, H1
Delisle, B1
Lapeyre-Mestre, M1
Pathak, A1
Montastruc, JL1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Mitral Valve Insufficiency

ArticleYear
Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:3

    Topics: Adult; Hallucinogens; Humans; Male; Mitral Valve Insufficiency; N-Methyl-3,4-methylenedioxyamphetami

2012